Interestingly, recent studies, including the mouse model of anti-MPO IgG mediated glomerulonephritis and human ANCA associated vasculitis, suggested that complement alternative pathway activation was crucial for ANCA associated vasculitis development [41–43]. The gene discussed is MPO; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.